医院起病脓毒症应扩大研究并视为独立临床实体
本文为综述,指出美国住院成人每年脓毒症死亡超过25万例,多数脓毒症为入院时存在,但高达四分之一的脓毒症患者在住院期间发生。与社区起病脓毒症(COS)相比,医院起病脓毒症(HOS)患者需要机械通气和ICU入住的可能性高2倍,ICU和住院时间延长超过2倍,住院费用高5倍,死亡可能性高2倍。HOS与COS在基础合并症、入院诊断、感染临床表现和疾病严重程度上存在差异。作者认为HOS研究不足,需扩大研究,并列出识别与管理方面的知识缺口和研究优先方向。
要点
- 美国住院成人每年脓毒症死亡超过25万例,高达四分之一的脓毒症为住院期间发生的医院起病脓毒症(HOS)。
- 与社区起病脓毒症(COS)相比,HOS患者需要机械通气和ICU入住的可能性高2倍,ICU和住院时间延长超过2倍。
- HOS患者住院费用较COS高5倍,死亡可能性高2倍。
- HOS与COS在基础合并症、入院诊断、感染临床表现和疾病严重程度上存在差异。
- 作者认为HOS研究不足,需扩大研究,并提出了标准化病例识别、理解临床异质性、制定量身定制管理建议等研究优先方向。
适用人群与场景
- 美国住院成人脓毒症患者。
- 医院起病脓毒症(HOS)指住院期间发生的脓毒症;社区起病脓毒症(COS)指入院时存在的脓毒症。
研究设计与关键结果
- 综述指出,美国住院成人每年脓毒症死亡超过25万例;多数脓毒症为入院时存在,但高达四分之一的脓毒症患者在住院期间发生。
- 与COS相比,HOS患者需要机械通气和ICU入住的可能性高2倍,ICU和住院时间延长超过2倍,住院费用高5倍,死亡可能性高2倍。
- HOS与COS在基础合并症、入院诊断、感染临床表现和疾病严重程度上存在差异。
- 作者列出HOS识别与管理的重要知识缺口和研究优先方向,包括研究和临床病例识别的标准化、理解HOS患者的临床异质性、制定量身定制的管理建议、识别有效的预防策略、优化护理提供和质量指标、识别和纠正护理与结局差异,以及确保HOS患者的目标一致护理。
证据类型、等级与局限
- 综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,HOS患者研究不足,需扩大研究,并提出了研究和临床病例识别标准化、理解临床异质性、制定量身定制管理建议、识别有效预防策略、优化护理提供和质量指标、识别和纠正护理与结局差异、确保目标一致护理等研究优先方向。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Sepsis causes more than a quarter million deaths among hospitalized adults in the United States each year. Although most cases of sepsis are present on admission, up to one-quarter of patients with sepsis develop this highly morbid and mortal condition while hospitalized. Compared with patients with community-onset sepsis (COS), patients with hospital-onset sepsis (HOS) are twice as likely to require mechanical ventilation and ICU admission, have more than two times longer ICU and hospital length of stay, accrue five times higher hospital costs, and are twice as likely to die. Patients with HOS differ from those with COS with respect to underlying comorbidities, admitting diagnosis, clinical manifestations of infection, and severity of illness. Despite the differences between these patient populations, patients with HOS sepsis are understudied and warrant expanded investigation. Here, we outline important knowledge gaps in the recognition and management of HOS in adults and propose associated research priorities for investigators. Of particular importance are questions regarding standardization of research and clinical case identification, understanding of clinical heterogeneity among patients with HOS, development of tailored management recommendations, identification of impactful prevention strategies, optimization of care delivery and quality metrics, identification and correction of disparities in care and outcomes, and how to ensure goal-concordant care for patients with HOS.
参考来源
- Ginestra JC, Coz Yataco AO, Dugar SP, et al. Hospital-Onset Sepsis Warrants Expanded Investigation and Consideration as a Unique Clinical Entity. Chest. 2024. PMID: 38246522. doi:10.1016/j.chest.2024.01.028
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。